Hence, as reported for other types of cancers (clear renal cell carcinoma3, oral squamous carcinoma (OSC)34, breast cancers, and melanoma33), NSCLC frequently overexpresses TLR3 compared to the normal bronchial epithelium, which warrants further investigation on targeting TLR3 in these cancers. The gene discussed is TLR3; the disease is cancer.